Anika Therapeutics, Inc. (NASDAQ:ANIK) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to Anika’s Second Quarter 2024 Earnings Conference Call.
Anika Therapeutics Inc. (ANIK)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Trigran Investments Douglas T. Granat | 2,136,232 | $54,110,757 | +4% | 5.65% |
| 2. | Renaissance Technologies Jim Simons | 598,229 | $15,153,141 | +7% | 0.02% |
| 3. | Alta Fundamental Advisers Jeremy Carton And Gilbert Li | 296,082 | $7,499,757 | +14% | 2.37% |
| 4. | Meros Investment Management Timothy Chatard | 212,714 | $5,388,046 | +26% | 2.54% |
| 5. | Stonepine Capital Timothy P. Lynch | 165,397 | $4,189,506 | +172% | 3.82% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $21.37 | 1,500 | Officer | 9,867 | 2022-05-11 | Filing | |
| $26.65 | 1,500 | Officer | 8,367 | 2022-03-14 | Filing | |
| $24.66 | 2,000 | Director | 17,121 | 2022-03-11 | Filing | |
| $25.81 | 3,813 | Officer, Director | 59,992 | 2022-03-11 | Filing | |
| $25.36 | 4,287 | Officer, Director | 56,179 | 2022-03-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $42.60 | 2,000 | Director | 7,953 | 2021-05-12 | Filing | |
| $36.77 | 3,446 | Director | 9,953 | 2020-11-10 | Filing | |
| $35.15 | 1,244 | Officer | 1,756 | 2020-07-09 | Filing | |
| $42.68 | 2,700 | Director | 13,399 | 2020-02-26 | Filing | |
| $59.71 | 20,000 | Officer | 47,741 | 2019-11-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,383,877 | $31,358,653 | 0% | |
| 2. | 1,081,360 | $24,503,618 | 8.26% | |
| 3. | 821,452 | $18,614,101 | 0% | |
| 4. | 764,045 | $17,313,259 | 0% | |
| 5. | 509,522 | $11,545,769 | 0.29% |
News See All
Top 10 Holdings of Caligan Partners
Founded in 2017, Caligan Partners is one of the most significant specialty hedge funds.
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2024 Earnings Call Transcript
Anika Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.30712 EPS, expectations were $-0.19. Anika Therapeutics, Inc.
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2023 Earnings Call Transcript
Anika Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-4.3 EPS, expectations were $-0.26.
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2023 Earnings Call Transcript
Operator: Good evening, ladies and gentlemen, and welcome to Anika's Third Quarter 2023 Earnings Conference Call. All participants' will be in a listen-only mode.
5 Recent Activist Investor Campaigns
Sleep Number, a company that offers sleep solutions and services in the United States, is also the subject of activist campaigns over deteriorating performance.
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q2 2023 Earnings Call Transcript
Operator: Good evening, ladies and gentlemen, and welcome to Anika's Second Quarter 2023 Earnings Conference Call. [Operator Instructions].
10 Oversold Small Cap Stocks To Buy
In this piece, we will take a look at the ten oversold small cap stocks to buy.
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to Anika's First Quarter 2023 Earnings Conference Call. [Operator Instructions] This call is being recorded on Tuesday, May 9, 2023.
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to Anika's Fourth Quarter and Year-End 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
